inclusion criteria: - participant is willing and able to give informed consent for participation in the study - first or repeat kidney transplant recipient - negative or low positive antibody titer on sars-cov-2 antibody assay - on a mycophenolate or azathioprine based immunosuppressive regimen - > 6 months post-transplant

inclusion criteria: - participant is willing and able to give informed consent for participation in the study - first or repeat kidney transplant recipient - negative or low positive antibody titer on sars-cov-2 antibody assay - on a mycophenolate or azathioprine based immunosuppressive regimen - > 6 months post-transplant